We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-11.91%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$529M
AUM Growth
-$226M
Cap. Flow
-$154M
Cap. Flow %
-29.11%
Top 10 Hldgs %
40.03%
Holding
118
New
32
Increased
20
Reduced
26
Closed
35

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$10.4M
2
MTD icon
Mettler-Toledo International
MTD
+$7.97M
3
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$6.5M
4
ELAN icon
Elanco Animal Health
ELAN
+$5.18M
5
PACB icon
Pacific Biosciences
PACB
+$4.74M

Top Sells

Rank Stock Value
1
OM icon
Outset Medical
OM
+$6.37M
2
RCM
R1 RCM Inc. Common Stock
RCM
+$5.89M
3
GH icon
Guardant Health
GH
+$4.1M
4
INSP icon
Inspire Medical Systems
INSP
+$3.7M
5
QTRX icon
Quanterix
QTRX
+$3.49M

Sector Composition

Rank Sector Weight
1 Healthcare 35.57%
2 Consumer Staples 1.71%
3 Industrials 0.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XNTK icon
26
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.25B
$7.3M 1.38%
100,000
-148,300
-60% -$21M
MTD icon
27
Mettler-Toledo International
MTD
$28.7B
$7.2M 1.36%
+6,500
New +$7.97M
RCEL icon
28
Avita Medical
RCEL
$242M
$7.02M 1.33%
480,643
+54,322
+13% +$919K
GEHC icon
29
PUT
GE HealthCare
GEHC
$32.8B
$6.8M 1.29%
+100,000
New +$7.28M
BSX icon
30
CALL
Boston Scientific
BSX
$74.2B
$6.6M 1.25%
125,000
+25,700
+26% +$1.35M
INMD icon
31
PUT
InMode
INMD
$873M
$6.09M 1.15%
200,000
+30,600
+18% +$1.2M
ABT icon
32
PUT
Abbott
ABT
$192B
$6.05M 1.14%
62,500
+14,100
+29% +$1.48M
HOLX
33
PUT
DELISTED
Hologic
HOLX
$5.9M 1.12%
+85,000
New +$6.42M
ARKG icon
34
PUT
ARK Genomic Revolution ETF
ARKG
$1.79B
$5.57M 1.05%
200,000
-148,900
-43% -$4.87M
LYRA
35
DELISTED
LYRA THERAPEUTICS INC
LYRA
$5.53M 1.05%
28,265
– –
SWAV
36
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$5.48M 1.04%
+27,500
New +$6.5M
SYK icon
37
PUT
Stryker
SYK
$132B
$5.47M 1.03%
20,000
-34,000
-63% -$9.75M
DXCM icon
38
PUT
DexCom
DXCM
$33.8B
$5.34M 1.01%
57,200
+44,800
+361% +$5.05M
ELAN icon
39
Elanco Animal Health
ELAN
$10.9B
$5.01M 0.95%
+445,914
New +$5.18M
A icon
40
PUT
Agilent Technologies
A
$42B
$3.91M 0.74%
35,000
+8,800
+34% +$1.05M
RCM
41
DELISTED
R1 RCM Inc. Common Stock
RCM
$3.71M 0.7%
245,929
-350,353
-59% -$5.89M
SONX
42
DELISTED
Sonendo, Inc.
SONX
$3.48M 0.66%
4,663,907
-8,238
-0.2% -$9.08K
PACB icon
43
Pacific Biosciences
PACB
$336M
$3.47M 0.66%
+415,000
New +$4.74M
EW icon
44
PUT
Edwards Lifesciences
EW
$53.5B
$3.46M 0.66%
+50,000
New +$4.02M
THC icon
45
PUT
Tenet Healthcare
THC
$21.2B
$3.29M 0.62%
+50,000
New +$3.74M
PODD icon
46
PUT
Insulet
PODD
$9.97B
$3.19M 0.6%
+20,000
New +$4.48M
ESTA icon
47
CALL
Establishment Labs
ESTA
$2.24B
$2.94M 0.56%
+59,900
New +$3.58M
STAA icon
48
PUT
STAAR Surgical
STAA
$1.26B
$2.81M 0.53%
+70,000
New +$3.28M
WAT icon
49
PUT
Waters Corp
WAT
$40.8B
$2.74M 0.52%
+10,000
New +$2.76M
QTRX icon
50
CALL
Quanterix
QTRX
$126M
$2.71M 0.51%
100,000
+7,100
+8% +$176K
1
2
3 4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2023 Portfolio in Review

As of Q3 2023, Pura Vida Investments held 118 positions worth $529M, down 30% from $755M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Pura Vida Investments withdrew a net $154M in Q3 2023, closing 35 positions and reducing 26 holdings. Its most notable exit was ViewRay, Inc., an estimated $3.09M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 30% a quarter earlier, followed by Consumer Staples and Industrials.

Against the trend, Pura Vida Investments opened a new position in Kenvue worth $9.06M.

  • Pura Vida Investments's largest Q3 2023 buy was Kenvue: 451,279 shares worth $9.06M.
  • Pura Vida Investments added most to Establishment Labs in Q3 2023, an estimated $3.18M increase.
  • Pura Vida Investments's biggest Q3 2023 reduction was Outset Medical, cutting an estimated $6.37M.
  • Pura Vida Investments fully exited ViewRay, Inc. in Q3 2023, selling an estimated $3.09M.
  • Pura Vida Investments's ten largest holdings make up 40% of its $529M portfolio in Q3 2023.
  • Pura Vida Investments opened 32 new positions and closed 35 in Q3 2023.
  • Pura Vida Investments's portfolio value fell 30% quarter-over-quarter to $529M.

Based on Pura Vida Investments's 13F filing for Q3 2023, filed 14 Nov 2023.